|
⚲
|
| Keyboard |
| Boyle Kevin S Sr
✚
|
|
|---|---|
| CIK # | 0001880600 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 3 | [0001880600] | |
| 4 | [0001880600] |
| Form 3/4/5 Subject | 2011 - 2026 |
|---|---|
| Ziopharm Oncology Inc | |
| Boyle Kevin S Sr |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Ziopharm Oncology Inc TCRT
Common Stock
|
2023-09-01 | Sell | 68,014 | $0.14 | 9,522 |
|
Ziopharm Oncology Inc TCRT
Employee Stock Option (right to buy) · derivative
|
2023-03-15 | Grant | 1,800,000 | $0.00 | |
|
Ziopharm Oncology Inc TCRT
Common Stock
|
2022-08-30 | Tax withheld | 18,750 | $2.41 | 45,188 |
|
Ziopharm Oncology Inc TCRT
Employee Stock Option (right to buy) · derivative
|
2022-03-30 | Grant | 2,000,000 | $0.00 | |
|
Ziopharm Oncology Inc ZIOP
Common Stock
|
2021-11-17 | Buy | 9,116 | $1.40 | 12,762 |
|
Ziopharm Oncology Inc ZIOP
Common Stock
|
2021-11-16 | Buy | 884 | $1.40 | 1,238 |
|
Ziopharm Oncology Inc ZIOP
Employee Stock Option (right to buy) · derivative
|
2021-08-30 | Grant | 2,625,000 | $0.00 | |
|
Ziopharm Oncology Inc ZIOP
Common Stock
|
2021-08-30 | Grant | 875,000 | $0.00 |